Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Testosterone therapy increases bone density in older men with low testosterone levels.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Minoxidil and finasteride effectively treat hair loss.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Early hair loss may indicate prostate issues.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Finasteride reduces prostate size and PSA levels in young patients.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.